Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin.

Marjolein Y A M Kroonen Jasper StevensDick de ZeeuwHiddo J Lambers Heerspink

Published in: Diabetes, obesity & metabolism (2019)

Individual variation in plasma concentrations of rosuvastatin and atorvastatin was associated with LDL-cholesterol changes in patients. The individual variation in UPCR change was not associated with the plasma concentration of both statins.

Keyphrases

end stage renal disease
low density lipoprotein
ejection fraction
newly diagnosed
chronic kidney disease
cardiovascular disease
peritoneal dialysis
type diabetes
patient reported outcomes